Sr. Scientist, Antibody Discovery and Engineering
Moderna
Summary
Moderna is seeking a highly motivated Senior Scientist to join the Antibody Discovery team within Therapeutics Research. This Senior Scientist will be a hands-on scientific contributor focused on protein and antibody engineering, with particular emphasis on yeast display-based discovery and optimization. The role will contribute to antibody discovery programs across oncology and autoimmune disease, applying experimental protein engineering from library and construct design through selection, characterization, optimization, and lead identification.
Job description
Here's What You'll Do
- Contribute to integrated antibody discovery and engineering campaigns, with primary responsibility for experimental protein and antibody engineering workstreams from design and library strategy through selection, characterization, optimization, and lead identification.
- Design, build, and execute yeast surface display workflows for antibody discovery and engineering, including library design and construction, FACS-based selections, affinity maturation, specificity and cross-reactivity optimization, and multi-parameter lead enrichment.
- Partner closely with computational protein design, bioinformatics, structural biology, and antigen design teams to translate in silico designs, sequence/structure hypotheses, and model predictions into experimentally testable constructs or libraries, and to use experimental results to inform subsequent design cycles.
- Apply molecular biology and protein engineering approaches including cloning, mutagenesis, sequence analysis, construct design, format conversion, expression, and purification across IgG, Fab, scFv, VHH, bispecific/multispecific, T cell engager, TCR engager, CAR-related, and other therapeutic formats.
- Characterize engineered candidates using biochemical, biophysical, display-based, and functional assays to assess binding, affinity, specificity, epitope diversity, expression, stability, developability, potency, and mechanism of action as appropriate.
- Analyze yeast-display selection data, sequence and NGS datasets, and orthogonal characterization data to identify structure-function relationships, nominate follow-up variants, and support data-driven lead selection.
- Independently formulate hypotheses, design complex experiments, troubleshoot technical challenges, and adapt experimental approaches to address critical program questions and scientific risks.
- Evaluate and implement new antibody/protein engineering methods, display technologies, and analysis approaches that can strengthen discovery quality, throughput, or molecular optimization.
- Communicate experimental plans, results, and recommendations clearly to cross-functional scientific teams and contribute to technical reports, project updates, and presentations.
- Coordinate effectively with internal collaborators and external partners, and provide scientific guidance or mentorship to research associates or junior colleagues as appropriate.
Here's What You'll Need (Basic Qualifications)
- PhD in protein engineering, molecular biology, biochemistry, immunology, cancer biology, or a related discipline, with 2+ years of relevant post-PhD industry experience in antibody discovery, protein engineering, antibody engineering, or biologics discovery.
- Strong hands-on experience with yeast surface display for antibody or protein engineering, including library design/construction, FACS-based screening or selection, affinity maturation, and/or specificity optimization.
- Strong technical foundation in antibody/protein structure-function relationships and the application of engineering approaches to improve binding, specificity, stability, expression, developability, or molecular format.
- Demonstrated experience collaborating with computational protein design, bioinformatics, structural biology, or related teams to translate computational/design hypotheses into experimental constructs or libraries and to provide experimental feedback that informs iterative design.
- Strong molecular biology and protein engineering skills, including cloning, mutagenesis, library construction, sequence analysis, expression construct design, protein/antibody expression, purification, and analytical characterization.
- Experience analyzing sequence-rich datasets generated from display selections or screening campaigns; familiarity with NGS-based library or repertoire analysis is strongly valued.
- Experience with antibody/protein characterization methods such as affinity determination, epitope binning, competition assays, specificity profiling, developability assessment, Biacore, Carterra, Octet, ELISA, MSD, flow cytometry, or related technologies.
- Demonstrated ability to independently design, execute, interpret, and troubleshoot complex experiments and to draw clear conclusions and next steps from multidisciplinary datasets.
- Experience working effectively across multidisciplinary teams and integrating experimental results with structural, computational, biochemical, and/or functional data.
- Ability to contribute to multiple projects simultaneously, coordinate experimental priorities and timelines, and communicate scientific risks, tradeoffs, and recommendations to project stakeholders.
- Excellent analytical, organizational, written, oral, and interpersonal communication skills, with the ability to present complex scientific findings clearly to diverse scientific audiences.
- Collaborative, proactive, resourceful approach to working in a fast-paced, cross-functional, matrixed research environment.
Here's What You'll Bring to the Table (Preferred Qualifications)
- Additional experience with advanced yeast or mammalian display approaches, including focused or combinatorial library design, deep sequencing, multiplexed selections, or high-throughput variant characterization.
- Experience working in iterative computational/experimental protein design workflows, including structure-guided design, de novo protein or binder design, AI/ML-enabled design tools, or developability prediction platforms.
- Experience engineering advanced antibody-based therapeutic formats such as T cell engagers, TCR engagers, bispecific or multispecific antibodies, ADCs, CAR-T or CAR-NK-related formats, or other non-canonical architectures.
- Experience with immunization-based or B cell-based antibody discovery, including antigen strategy, single-cell screening, sequence recovery, or repertoire analysis.
- Familiarity with functional cell-based assays, immune-cell biology, primary-cell assays, or immune-cell redirecting therapeutic mechanisms.
- Experience applying antibody or protein engineering approaches across oncology, autoimmune, infectious disease, or other therapeutically relevant areas.
- Track record of scientific impact through therapeutic discovery programs, publications, patents, presentations, implementation of new engineering technologies, or mentorship of junior scientists.
Our Working Model
This role is 100% onsite, reflecting the importance of being physically present to support the work, collaborate closely with colleagues, and contribute to our site-based operations.
Requirements
- PhD in protein engineering, molecular biology, biochemistry, immunology, cancer biology, or a related discipline
- 2+ years of relevant post-PhD industry experience in antibody discovery, protein engineering, antibody engineering, or biologics discovery
- Strong hands-on experience with yeast surface display for antibody or protein engineering, including library design/construction, FACS-based screening or selection, affinity maturation, and/or specificity optimization
- Strong technical foundation in antibody/protein structure-function relationships and the application of engineering approaches to improve binding, specificity, stability, expression, developability, or molecular format
- Demonstrated experience collaborating with computational protein design, bioinformatics, structural biology, or related teams to translate computational/design hypotheses into experimental constructs or libraries and to provide experimental feedback that informs iterative design
- Strong molecular biology and protein engineering skills, including cloning, mutagenesis, library construction, sequence analysis, expression construct design, protein/antibody expression, purification, and analytical characterization
- Experience analyzing sequence-rich datasets generated from display selections or screening campaigns; familiarity with NGS-based library or repertoire analysis is strongly valued
- Experience with antibody/protein characterization methods such as affinity determination, epitope binning, competition assays, specificity profiling, developability assessment, Biacore, Carterra, Octet, ELISA, MSD, flow cytometry, or related technologies
- Demonstrated ability to independently design, execute, interpret, and troubleshoot complex experiments and to draw clear conclusions and next steps from multidisciplinary datasets
- Experience working effectively across multidisciplinary teams and integrating experimental results with structural, computational, biochemical, and/or functional data
- Ability to contribute to multiple projects simultaneously, coordinate experimental priorities and timelines, and communicate scientific risks, tradeoffs, and recommendations to project stakeholders
- Excellent analytical, organizational, written, oral, and interpersonal communication skills, with the ability to present complex scientific findings clearly to diverse scientific audiences
- Collaborative, proactive, resourceful approach to working in a fast-paced, cross-functional, matrixed research environment
Benefits
- Competitive healthcare
- Voluntary benefit programs
- Fitness support
- Mindfulness support
- Mental health support
- Fertility support
- Adoption support
- Surrogacy support
- Generous paid time off
- Volunteer days
- Sabbatical
- Global recharge days
- Year-end shutdown
- Savings and investments
- Location-specific perks
Company overview
Moderna, Inc. is a pioneering American biotechnology and pharmaceutical company headquartered in Cambridge, Massachusetts, that has revolutionized the field of medicine through its groundbreaking messenger RNA (mRNA) technology. Founded in 2010, the company has established itself as a global leader in RNA therapeutics, primarily focusing on mRNA vaccines and treatments. Moderna's innovative platform uses mRNA to provide cellular instructions for producing proteins that trigger immune responses, creating a new category of medicines with significant potential to improve patient outcomes across various therapeutic areas. The company gained worldwide recognition during the COVID-19 pandemic for developing one of the earliest and most effective mRNA vaccines, which demonstrated the transformative potential of its technology platform. Beyond infectious diseases, Moderna is advancing a diverse pipeline of 44 treatment and vaccine candidates across infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune conditions. With approximately 5,800 employees and a strong commitment to scientific innovation, Moderna continues to expand its manufacturing capabilities and research initiatives to deliver the greatest possible impact through mRNA medicines.